Bradley John Molyneaux, M.D., M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glyburide | 7 | 2022 | 114 | 0.950 |
Why?
|
Brain Stem Infarctions | 1 | 2023 | 31 | 0.860 |
Why?
|
Brain Edema | 8 | 2022 | 603 | 0.850 |
Why?
|
Thrombectomy | 8 | 2020 | 708 | 0.820 |
Why?
|
Stroke | 19 | 2022 | 9935 | 0.780 |
Why?
|
Infarction | 1 | 2023 | 248 | 0.780 |
Why?
|
Cerebral Infarction | 4 | 2020 | 982 | 0.720 |
Why?
|
Neocortex | 3 | 2014 | 416 | 0.620 |
Why?
|
Motor Neurons | 5 | 2014 | 864 | 0.580 |
Why?
|
Gene Expression Regulation, Developmental | 7 | 2014 | 3600 | 0.540 |
Why?
|
Pyramidal Tracts | 5 | 2014 | 250 | 0.500 |
Why?
|
Blood Coagulation Factors | 1 | 2016 | 366 | 0.470 |
Why?
|
Carotid Artery, Common | 1 | 2014 | 177 | 0.440 |
Why?
|
Intracranial Hemorrhages | 3 | 2018 | 844 | 0.420 |
Why?
|
Pyramidal Cells | 1 | 2014 | 369 | 0.410 |
Why?
|
Vasospasm, Intracranial | 1 | 2014 | 214 | 0.400 |
Why?
|
Cell Differentiation | 8 | 2014 | 11476 | 0.370 |
Why?
|
Brain Ischemia | 6 | 2019 | 3128 | 0.360 |
Why?
|
Corpus Callosum | 3 | 2014 | 749 | 0.340 |
Why?
|
Endarterectomy, Carotid | 1 | 2014 | 560 | 0.320 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2019 | 2774 | 0.310 |
Why?
|
Warfarin | 1 | 2016 | 1516 | 0.300 |
Why?
|
Efferent Pathways | 2 | 2008 | 165 | 0.300 |
Why?
|
Recovery of Function | 5 | 2021 | 2979 | 0.290 |
Why?
|
Neurons | 8 | 2014 | 9411 | 0.270 |
Why?
|
Software | 1 | 2019 | 4421 | 0.250 |
Why?
|
Eligibility Determination | 2 | 2019 | 419 | 0.240 |
Why?
|
Endovascular Procedures | 4 | 2018 | 2137 | 0.230 |
Why?
|
Patient Selection | 4 | 2019 | 4269 | 0.220 |
Why?
|
Hypoxanthine | 1 | 2022 | 28 | 0.210 |
Why?
|
Cerebral Cortex | 3 | 2008 | 5754 | 0.210 |
Why?
|
Stents | 1 | 2014 | 3308 | 0.200 |
Why?
|
Receptors, GABA-B | 1 | 2002 | 58 | 0.200 |
Why?
|
Medulla Oblongata | 1 | 2023 | 248 | 0.200 |
Why?
|
Anticoagulants | 1 | 2016 | 4897 | 0.180 |
Why?
|
Shab Potassium Channels | 1 | 2020 | 20 | 0.180 |
Why?
|
Hypoglycemic Agents | 3 | 2018 | 3150 | 0.180 |
Why?
|
Theta Rhythm | 1 | 2002 | 217 | 0.170 |
Why?
|
Nerve Tissue Proteins | 5 | 2014 | 4409 | 0.170 |
Why?
|
Tomography, X-Ray Computed | 3 | 2019 | 20461 | 0.170 |
Why?
|
Presynaptic Terminals | 1 | 2002 | 301 | 0.170 |
Why?
|
Saline Solution, Hypertonic | 1 | 2020 | 113 | 0.170 |
Why?
|
Mannitol | 1 | 2020 | 180 | 0.170 |
Why?
|
RNA, Messenger | 1 | 2014 | 12774 | 0.170 |
Why?
|
Hydrocarbons, Chlorinated | 1 | 2020 | 119 | 0.160 |
Why?
|
Middle Cerebral Artery | 1 | 2020 | 274 | 0.160 |
Why?
|
Comprehensive Health Care | 1 | 2019 | 124 | 0.160 |
Why?
|
Spinal Cord | 1 | 2007 | 1815 | 0.160 |
Why?
|
Intracranial Thrombosis | 1 | 2019 | 109 | 0.160 |
Why?
|
Remote Consultation | 1 | 2021 | 235 | 0.160 |
Why?
|
Patient Transfer | 3 | 2024 | 775 | 0.150 |
Why?
|
Neural Inhibition | 1 | 2002 | 589 | 0.150 |
Why?
|
Heart Arrest | 2 | 2019 | 1503 | 0.150 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 1 | 2019 | 150 | 0.150 |
Why?
|
Stem Cells | 2 | 2008 | 3525 | 0.150 |
Why?
|
Carotid Artery, Internal | 1 | 2020 | 434 | 0.150 |
Why?
|
Emergency Service, Hospital | 3 | 2024 | 7788 | 0.140 |
Why?
|
Cerebrum | 1 | 2018 | 132 | 0.140 |
Why?
|
Hospice Care | 1 | 2024 | 692 | 0.140 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2020 | 486 | 0.140 |
Why?
|
Shock, Hemorrhagic | 1 | 2018 | 225 | 0.130 |
Why?
|
DNA-Binding Proteins | 3 | 2014 | 9590 | 0.130 |
Why?
|
Fluid Therapy | 1 | 2020 | 592 | 0.130 |
Why?
|
Shivering | 1 | 2015 | 11 | 0.130 |
Why?
|
Myoclonus | 1 | 2016 | 106 | 0.130 |
Why?
|
Tumor Suppressor Proteins | 3 | 2014 | 2804 | 0.130 |
Why?
|
Neuroprotective Agents | 2 | 2020 | 960 | 0.130 |
Why?
|
Ischemic Attack, Transient | 1 | 2021 | 899 | 0.130 |
Why?
|
International Normalized Ratio | 1 | 2016 | 386 | 0.120 |
Why?
|
Disability Evaluation | 2 | 2021 | 1826 | 0.120 |
Why?
|
Repressor Proteins | 3 | 2014 | 2981 | 0.120 |
Why?
|
Matrix Attachment Region Binding Proteins | 1 | 2014 | 47 | 0.120 |
Why?
|
Nitriles | 1 | 2020 | 954 | 0.120 |
Why?
|
Adrenergic alpha-2 Receptor Agonists | 1 | 2015 | 91 | 0.120 |
Why?
|
Methyl-CpG-Binding Protein 2 | 1 | 2016 | 187 | 0.120 |
Why?
|
Out-of-Hospital Cardiac Arrest | 1 | 2018 | 346 | 0.120 |
Why?
|
Rett Syndrome | 1 | 2016 | 164 | 0.120 |
Why?
|
Pulvinar | 1 | 2013 | 21 | 0.110 |
Why?
|
In Situ Hybridization | 2 | 2009 | 1900 | 0.110 |
Why?
|
Patient Admission | 2 | 2021 | 1383 | 0.110 |
Why?
|
Water | 1 | 2019 | 1401 | 0.110 |
Why?
|
Middle Aged | 21 | 2024 | 219653 | 0.110 |
Why?
|
Aged, 80 and over | 9 | 2024 | 58867 | 0.110 |
Why?
|
Aged | 19 | 2024 | 168617 | 0.100 |
Why?
|
Cerebral Hemorrhage | 1 | 2024 | 2659 | 0.100 |
Why?
|
Electroencephalography | 2 | 2018 | 6174 | 0.100 |
Why?
|
Nervous System Diseases | 1 | 2022 | 1645 | 0.100 |
Why?
|
Bromodeoxyuridine | 3 | 2008 | 310 | 0.100 |
Why?
|
NF-kappa B | 2 | 2022 | 2486 | 0.100 |
Why?
|
Functional Laterality | 1 | 2018 | 2253 | 0.100 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2019 | 1001 | 0.100 |
Why?
|
Cerebral Angiography | 1 | 2017 | 1266 | 0.100 |
Why?
|
Mice | 14 | 2022 | 81138 | 0.100 |
Why?
|
Tissue and Organ Procurement | 1 | 2019 | 941 | 0.090 |
Why?
|
Animals | 18 | 2022 | 167838 | 0.090 |
Why?
|
Dexmedetomidine | 1 | 2015 | 315 | 0.090 |
Why?
|
Brain Injuries | 1 | 2022 | 2043 | 0.090 |
Why?
|
Neurotransmitter Agents | 1 | 2014 | 661 | 0.090 |
Why?
|
Male | 25 | 2024 | 358719 | 0.090 |
Why?
|
Humans | 34 | 2024 | 759255 | 0.090 |
Why?
|
Hypothermia, Induced | 1 | 2015 | 758 | 0.090 |
Why?
|
Tissue Donors | 1 | 2019 | 2301 | 0.090 |
Why?
|
Cerebrovascular Circulation | 1 | 2020 | 2725 | 0.090 |
Why?
|
Female | 25 | 2024 | 390240 | 0.090 |
Why?
|
Mice, Inbred C57BL | 7 | 2022 | 21981 | 0.080 |
Why?
|
Inpatients | 1 | 2021 | 2580 | 0.080 |
Why?
|
Enzyme Inhibitors | 1 | 2020 | 3724 | 0.080 |
Why?
|
Predictive Value of Tests | 3 | 2020 | 15264 | 0.080 |
Why?
|
Nerve Degeneration | 1 | 2013 | 748 | 0.080 |
Why?
|
Neural Pathways | 3 | 2009 | 3039 | 0.080 |
Why?
|
Molecular Targeted Therapy | 1 | 2020 | 2803 | 0.080 |
Why?
|
Retrospective Studies | 12 | 2021 | 80121 | 0.080 |
Why?
|
Animals, Newborn | 4 | 2008 | 2675 | 0.080 |
Why?
|
Neurogenesis | 1 | 2014 | 854 | 0.080 |
Why?
|
In Situ Nick-End Labeling | 2 | 2008 | 613 | 0.080 |
Why?
|
Status Epilepticus | 1 | 2013 | 456 | 0.080 |
Why?
|
Syndrome | 1 | 2014 | 3276 | 0.080 |
Why?
|
Time Factors | 8 | 2021 | 40109 | 0.070 |
Why?
|
Hypnotics and Sedatives | 1 | 2015 | 1177 | 0.070 |
Why?
|
Gene Expression Regulation | 2 | 2016 | 11908 | 0.070 |
Why?
|
Cell Surface Extensions | 1 | 2007 | 66 | 0.070 |
Why?
|
Green Fluorescent Proteins | 3 | 2008 | 2056 | 0.070 |
Why?
|
Embryo, Mammalian | 3 | 2008 | 1666 | 0.070 |
Why?
|
Genes, Homeobox | 1 | 2007 | 283 | 0.070 |
Why?
|
Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2005 | 29 | 0.070 |
Why?
|
Seizures | 1 | 2018 | 2908 | 0.060 |
Why?
|
POU Domain Factors | 1 | 2005 | 47 | 0.060 |
Why?
|
Annexin A2 | 1 | 2005 | 44 | 0.060 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2005 | 127 | 0.060 |
Why?
|
Cell Cycle Proteins | 2 | 2008 | 3449 | 0.060 |
Why?
|
Cell Count | 2 | 2008 | 1837 | 0.060 |
Why?
|
Severity of Illness Index | 2 | 2020 | 15815 | 0.060 |
Why?
|
S100 Proteins | 1 | 2005 | 218 | 0.060 |
Why?
|
Basal Ganglia Hemorrhage | 1 | 2024 | 7 | 0.060 |
Why?
|
Brain | 3 | 2022 | 26863 | 0.060 |
Why?
|
Growth Cones | 1 | 2005 | 117 | 0.060 |
Why?
|
Flow Cytometry | 1 | 2014 | 5870 | 0.060 |
Why?
|
Coma | 2 | 2018 | 487 | 0.060 |
Why?
|
Base Sequence | 1 | 2014 | 12450 | 0.060 |
Why?
|
Mice, Knockout | 5 | 2016 | 14381 | 0.060 |
Why?
|
Carrier Proteins | 2 | 2008 | 4939 | 0.050 |
Why?
|
Radiography | 1 | 2014 | 6964 | 0.050 |
Why?
|
Treatment Outcome | 8 | 2024 | 64879 | 0.050 |
Why?
|
Genetic Markers | 1 | 2009 | 2608 | 0.050 |
Why?
|
Neuroendoscopy | 1 | 2024 | 97 | 0.050 |
Why?
|
Phosphinic Acids | 1 | 2002 | 17 | 0.050 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2008 | 1132 | 0.050 |
Why?
|
GABA Antagonists | 1 | 2002 | 120 | 0.050 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 17629 | 0.050 |
Why?
|
Nuclear Proteins | 2 | 2008 | 5793 | 0.050 |
Why?
|
Signal Transduction | 2 | 2016 | 23362 | 0.050 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2005 | 801 | 0.050 |
Why?
|
Hypertension | 1 | 2022 | 8594 | 0.050 |
Why?
|
Propanolamines | 1 | 2002 | 162 | 0.050 |
Why?
|
Corpus Striatum | 1 | 2008 | 1232 | 0.050 |
Why?
|
Thalamus | 1 | 2008 | 1041 | 0.050 |
Why?
|
Second Messenger Systems | 1 | 2002 | 202 | 0.050 |
Why?
|
Motor Cortex | 2 | 2008 | 994 | 0.050 |
Why?
|
Nerve Regeneration | 1 | 2007 | 790 | 0.050 |
Why?
|
Gene Expression Profiling | 2 | 2014 | 9374 | 0.040 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2005 | 1135 | 0.040 |
Why?
|
Cell Death | 1 | 2005 | 1669 | 0.040 |
Why?
|
Decompressive Craniectomy | 1 | 2020 | 76 | 0.040 |
Why?
|
Rotarod Performance Test | 1 | 2019 | 63 | 0.040 |
Why?
|
Amino Acids | 1 | 2005 | 1715 | 0.040 |
Why?
|
Osmolar Concentration | 1 | 2020 | 662 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2008 | 2867 | 0.040 |
Why?
|
Length of Stay | 2 | 2024 | 6452 | 0.040 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2022 | 633 | 0.040 |
Why?
|
Neuronal Plasticity | 1 | 2007 | 1428 | 0.040 |
Why?
|
Infusions, Subcutaneous | 1 | 2018 | 43 | 0.040 |
Why?
|
Phenotype | 1 | 2016 | 16532 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 2 | 2023 | 36160 | 0.040 |
Why?
|
Membrane Glycoproteins | 2 | 2008 | 3730 | 0.040 |
Why?
|
Stilbamidines | 2 | 2008 | 43 | 0.040 |
Why?
|
Cell Lineage | 1 | 2007 | 2524 | 0.040 |
Why?
|
Adult | 8 | 2019 | 219390 | 0.040 |
Why?
|
Forkhead Transcription Factors | 1 | 2005 | 1612 | 0.040 |
Why?
|
Pennsylvania | 1 | 2019 | 615 | 0.040 |
Why?
|
Mice, Transgenic | 4 | 2014 | 9528 | 0.040 |
Why?
|
Cell Movement | 2 | 2008 | 5209 | 0.040 |
Why?
|
Glasgow Outcome Scale | 1 | 2017 | 104 | 0.030 |
Why?
|
Transcription Factors | 2 | 2014 | 12106 | 0.030 |
Why?
|
Brain Death | 1 | 2019 | 356 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2018 | 15672 | 0.030 |
Why?
|
Homeodomain Proteins | 1 | 2005 | 2415 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2024 | 2322 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 2018 | 1388 | 0.030 |
Why?
|
Interleukin-1 Receptor-Associated Kinases | 1 | 2016 | 76 | 0.030 |
Why?
|
Endpoint Determination | 1 | 2018 | 597 | 0.030 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2002 | 1132 | 0.030 |
Why?
|
Vascular System Injuries | 1 | 2018 | 247 | 0.030 |
Why?
|
Glasgow Coma Scale | 1 | 2017 | 579 | 0.030 |
Why?
|
Postoperative Hemorrhage | 1 | 2018 | 422 | 0.030 |
Why?
|
Genes, Suppressor | 1 | 2014 | 47 | 0.030 |
Why?
|
Intracranial Pressure | 1 | 2017 | 325 | 0.030 |
Why?
|
Double-Blind Method | 2 | 2020 | 12386 | 0.030 |
Why?
|
Clinical Trials as Topic | 2 | 2020 | 8055 | 0.030 |
Why?
|
Area Under Curve | 1 | 2017 | 1634 | 0.030 |
Why?
|
Terminal Care | 1 | 2024 | 1757 | 0.030 |
Why?
|
Body Temperature | 1 | 2015 | 777 | 0.030 |
Why?
|
Postoperative Care | 1 | 2018 | 1478 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2005 | 11058 | 0.020 |
Why?
|
Hospitalization | 2 | 2024 | 10734 | 0.020 |
Why?
|
Aftercare | 1 | 2017 | 919 | 0.020 |
Why?
|
Fever | 1 | 2018 | 1619 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2002 | 8157 | 0.020 |
Why?
|
Anesthesia | 1 | 2002 | 1580 | 0.020 |
Why?
|
Prospective Studies | 3 | 2020 | 54204 | 0.020 |
Why?
|
Models, Biological | 1 | 2007 | 9466 | 0.020 |
Why?
|
Triage | 1 | 2017 | 982 | 0.020 |
Why?
|
Hyperglycemia | 1 | 2018 | 1378 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2019 | 18110 | 0.020 |
Why?
|
Hippocampus | 1 | 2002 | 3727 | 0.020 |
Why?
|
ROC Curve | 1 | 2017 | 3570 | 0.020 |
Why?
|
Quality Improvement | 1 | 2024 | 3836 | 0.020 |
Why?
|
Anticonvulsants | 1 | 2018 | 1879 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2017 | 21988 | 0.020 |
Why?
|
Phosphorylation | 1 | 2020 | 8313 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2013 | 1833 | 0.020 |
Why?
|
Family | 1 | 2019 | 3189 | 0.020 |
Why?
|
Age Factors | 1 | 2005 | 18394 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2005 | 7851 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8549 | 0.020 |
Why?
|
Receptor, Muscarinic M4 | 1 | 2008 | 16 | 0.020 |
Why?
|
Telencephalon | 1 | 2008 | 142 | 0.020 |
Why?
|
SOXD Transcription Factors | 1 | 2008 | 44 | 0.020 |
Why?
|
Kidney Diseases | 1 | 2018 | 2092 | 0.020 |
Why?
|
Pilot Projects | 1 | 2021 | 8540 | 0.020 |
Why?
|
Patient Readmission | 1 | 2021 | 3323 | 0.020 |
Why?
|
Electroporation | 1 | 2008 | 256 | 0.020 |
Why?
|
Young Adult | 3 | 2018 | 58483 | 0.020 |
Why?
|
Rats | 1 | 2002 | 23694 | 0.020 |
Why?
|
Contrast Media | 1 | 2018 | 5302 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2008 | 748 | 0.020 |
Why?
|
Somatosensory Cortex | 1 | 2008 | 510 | 0.010 |
Why?
|
Superior Colliculi | 1 | 2005 | 98 | 0.010 |
Why?
|
Body Patterning | 1 | 2008 | 630 | 0.010 |
Why?
|
Heart Rate | 1 | 2015 | 4165 | 0.010 |
Why?
|
Blood Glucose | 1 | 2018 | 6368 | 0.010 |
Why?
|
Mitosis | 1 | 2008 | 1195 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2014 | 5789 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 8000 | 0.010 |
Why?
|
Registries | 1 | 2018 | 8434 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2008 | 1756 | 0.010 |
Why?
|
Prevalence | 1 | 2019 | 15641 | 0.010 |
Why?
|
Nerve Growth Factors | 1 | 2005 | 562 | 0.010 |
Why?
|
Incidence | 1 | 2019 | 21336 | 0.010 |
Why?
|
Blood Pressure | 1 | 2015 | 8523 | 0.010 |
Why?
|
ras Proteins | 1 | 2005 | 1051 | 0.010 |
Why?
|
Adolescent | 2 | 2018 | 87560 | 0.010 |
Why?
|
Quality of Life | 1 | 2018 | 13284 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2005 | 3774 | 0.010 |
Why?
|
Prognosis | 1 | 2016 | 29561 | 0.010 |
Why?
|
Risk Factors | 1 | 2018 | 74167 | 0.010 |
Why?
|
Pregnancy | 1 | 2008 | 29658 | 0.000 |
Why?
|